VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background and Objectives: Irritable bowel syndrome (IBS) is a common problem in pediatrics, for which no safe and effective treatment is available. Probiotics have shown some promising results in adult studies, but no positive study has been published on pediatric age. We aimed at investigating the efficacy of VSL#3 in a population of children and teenagers affected by IBS, in a randomized, double‐blind, placebo‐controlled, crossover study conducted in 7 pediatric gastroenterology divisions. Patients and Methods: Children 4 to 18 years of age, meeting eligibility criteria, were enrolled. The patients were assessed by a questionnaire for a 2‐week baseline period. They were then randomized to receive either VSL#3 or a placebo for 6 weeks, with controls every 2 weeks. At the end, after a “wash‐out” period of 2 weeks, each patient was switched to the other group and followed for a further 6 weeks. Results: A total of 59 children completed the study. Although placebo was effective in some of the parameters and in as many as half of the patients, VSL#3 was significantly superior to it ( P < 0.05) in the primary endpoint, the subjective assessment of relief of symptoms; as well as in 3 of 4 secondary endpoints: abdominal pain/discomfort ( P < 0.05), abdominal bloating/gassiness ( P < 0.05), and family assessment of life disruption ( P < 0.01). No significant difference was found ( P = 0.06) in the stool pattern. No untoward adverse effect was recorded in any of the patients. Conclusions: VSL#3 is safe and more effective than placebo in ameliorating symptoms and improving the quality of life in children affected by IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study found that VSL#3 improved GI symptoms134”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [134]
In the citing paper
“Similarly, patients in the VSL#3 trial had decreased abdominal bloating/gassiness compared to placebo134.”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [134]
In the citing paper
“Other smaller studies reported some beneficial effects with other probiotic strains including Bifidobacterium animalis DN-173 010 (74), Bifidobacterium bifidum MIMBb75 (72), Lactobacillus plantarum 299V (117), Saccharomyces boulardii (37), and combination of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 (144) and multispecies probiotic mixtures (71, 87, 88).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [71]
Citations
Cites
2 retracted
Huertas-Ceballos, A. A., Logan, S., Bennett, C., & Macarthur, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003017.pub2 · Cited by 207
RetractedHuertas‐Ceballos, A., Logan, S., Bennett, C., & Macarthur, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003019.pub3 · Cited by 82
RetractedSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · cited 1×
“One of the most promising developments in our understanding of IBS and, thus of its potential treatment, was the recognition that many episodes of IBS can be traced to intestinal infections (18– 20), and that disturbances of the intestinal microbiota (including higher numbers of facultative organisms and low numbers o…”
Childhood functional gastrointestinal disorders
Rasquin-Weber, A., Hyman, P. E., Cucchiara, S., Fleisher, D. R., Hyams, J. S., Milla, P. J., & Staiano, A. (1999) · Gut · doi:10.1136/gut.45.2008.ii60 · Cited by 814
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · cited 1×
“One of the most promising developments in our understanding of IBS and, thus of its potential treatment, was the recognition that many episodes of IBS can be traced to intestinal infections (18– 20), and that disturbances of the intestinal microbiota (including higher numbers of facultative organisms and low numbers o…”
Abdominal pain and irritable bowel syndrome in adolescents: a community-based study
Hyams, J. S., Burke, G., Davis, P. M., Rzepski, B., & Andrulonis, P. A. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70246-9 · Cited by 532 · cited 6×
“IBS in children and adolescents accounts for a significant number (2%–4%) of office visits to primary care physicians (1,4,5).”
InfluentialKim, H. J., Camilleri, M., Mckinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M., & Zinsmeister, A. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01543.x · Cited by 468
Kim, H. J., Vazquez Roque, M. I., Camilleri, M., Stephens, D., Burton, D. D., Baxter, K., Thomforde, G., & Zinsmeister, A. R. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00695.x · Cited by 400 · cited 3×
“In their studies, these investigators found that VSL#3 was significantly effective in ameliorating abdominal bloating (11) and improving the symptom of flatulence while prolonging colonic transit time (12) in adults with IBS; however, no statistically significant effect could be shown for the other parameters investig…”
Cited by
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
Hyams, J. S., Di Lorenzo, C., Saps, M., Shulman, R. J., Staiano, A., & van Tilburg, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.015 · Cited by 1,362
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Actinobacteria: A relevant minority for the maintenance of gut homeostasis
Binda, C., Lopetuso, L. R., Rizzatti, G., Gibiino, G., Cennamo, V., & Gasbarrini, A. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.02.012 · Cited by 815
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Metadata
- Authors
- Guandalini, S., Magazzù, G., Chiaro, A., La Balestra, V., Di Nardo, G., Gopalan, S., Sibal, A., Romano, C., Canani, R. B., Lionetti, P., & Setty, M.
- Affiliations
- University of Chicago (US)
- University of Messina (IT)
- University of Rome “La Sapienza” Rome Italy
- CRNSS New Delhi India
- Federico II University Hospital (IT)
- University of Florence (IT)
- Corresponding author
- Guandalini, Stefano
- Setty, Mala
- ORCID
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2010-07
- Volume
- 51
- Issue
- 1
- Pages
- 24-30
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2005532504
- Cited by
- 273
- References
- 32
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 15 · 2023: 11 · 2022: 20 · 2021: 17 · 2020: 15 · 2019: 12 · 2018: 24 · 2017: 13 · 2016: 20 · 2015: 19 · 2014: 23 · 2013: 22 · 2012: 24
- FWCI
- 23.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, VSL#3, probiotics, children, adolescents, symptom relief, abdominal pain, bloating, quality of life, placebo comparison
- MeSH terms
- Adolescent, Child, Child, Preschool, Double-Blind Method, Family, Female, Humans, Male, Surveys and Questionnaires, Abdominal Pain, Treatment Outcome, Cross-Over Studies, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. https://app.cochat.ai/papers/10.1097/mpg.0b013e3181ca4d95
- The paper
- Guandalini, S., Magazzù, G., Chiaro, A., La Balestra, V., Di Nardo, G., Gopalan, S., Sibal, A., Romano, C., Canani, R. B., Lionetti, P., & Setty, M. (2010). VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0b013e3181ca4d95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.